Order Article Reprints

Scuderi SA, Filippone A, Basilotta R, Mannino D, Casili G, Capra AP, Chisari G, Colarossi L, Sava S, Campolo M, et al. GSK343, an Inhibitor of Enhancer of Zeste Homolog 2, Reduces Glioblastoma Progression through Inflammatory Process Modulation: Focus on Canonical and Non-Canonical NF-κB/IκBα Pathways. International Journal of Molecular Sciences. 2022; 23(22):13915. https://doi.org/10.3390/ijms232213915

Scuderi, Sarah Adriana, Alessia Filippone, Rossella Basilotta, Deborah Mannino, Giovanna Casili, Anna Paola Capra, Giulia Chisari, Lorenzo Colarossi, Serena Sava, Michela Campolo, and et al. 2022. "GSK343, an Inhibitor of Enhancer of Zeste Homolog 2, Reduces Glioblastoma Progression through Inflammatory Process Modulation: Focus on Canonical and Non-Canonical NF-κB/IκBα Pathways" International Journal of Molecular Sciences 23, no. 22: 13915. https://doi.org/10.3390/ijms232213915

Scuderi, S. A., Filippone, A., Basilotta, R., Mannino, D., Casili, G., Capra, A. P., Chisari, G., Colarossi, L., Sava, S., Campolo, M., Esposito, E., & Paterniti, I. (2022). GSK343, an Inhibitor of Enhancer of Zeste Homolog 2, Reduces Glioblastoma Progression through Inflammatory Process Modulation: Focus on Canonical and Non-Canonical NF-κB/IκBα Pathways. International Journal of Molecular Sciences, 23(22), 13915. https://doi.org/10.3390/ijms232213915